Material and Method: Human telomerase reverse transcriptase, a protein implicated as a proliferation marker, was chosen relevant to its expression in solid tumors along with 3 other intracellular proteins exhibiting nuclear and/or cytoplasmic expression. Staining was performed on 10 glioma tissue sections along with 5 of their cryo sections, 5 sections each of hepatocellular, lung, papillary-thyroid and renal cell carcinoma, with 10 non-malignant brain tissue samples serving as control. Specimens were imaged using epifluorescence microscopy, followed by software-based quantification of fluorescence signals for statistical analysis and validation.
Results: We observed that the combined application of sodium-borohydride followed by crystal violet before antigen retrieval and a Sudan black B treatment after secondary antibody application proved to be most efficacious for masking autofluorescence/non-specific background in vascular tissues.
Conclusion: This unique trio-methodology provides quantifiable observations with maximized fluorescence signal intensity of the target protein for longer retention time of the signal even after prolonged storage. The results can be extrapolated to other human tissues for different protein targets.
Autofluorescence induced interference is one of the major hitches in IF analysis of FFPE tissues, as it decreases the signal-to-noise ratio of specific labeling. The greatest source of autofluorescence in mammalian tissues is artifacts due to aldehyde fixation along with endogenous fluorophores: collagen, elastin, lipofuscin, red blood cells, and others. Vascular tissues contain massive amounts of collagen and elastin, along with haem, which are typical constituents of blood vessels[5-7], while lipofuscin is known to accumulate with aging and oxidative stress in various tissues[8,9]. Under a fluorescence or confocal microscope, lipofuscin appears as tiny, dot like structures within the cells, strongly fluorescing over a wide excitation range of 360-647 nm[10], which overlaps with the commonly used fluorophores and interferes with specific immuno-fluorescent signals[11]. In the present method validation, we describe the optimized indirect IF method on vascular, archival FFPE tissues and cryo sections.
Glioma (brain tumor), being highly vascular, proliferative and invasive, was considered for the present study. The technique was also performed on brain cryo-sections and non-malignant brain tissue sections along with lung, kidney and thyroid tissue sections and their results were compared for reproducibility. Expression of protein human Telomerase Reverse Transcriptase (hTERT), implicated as a proliferation marker in various cancers[12-14], was used to verify and replicate the procedure, and quantitatively analyze and statistically validate the methodology using fluorescence tagged antibody. Subsequently, expression of other nuclear and cytoplasmic fluorescein isothiocyanate (FITC) tagged protein targets, namely High Mobility GroupA1 (HMGA1), Kinesin Family Member14 (KIF-14) and Synaptophysin, was also checked on glioma tissues.
The specific labelling of hTERT protein in selected tissuesections by immuno-florescence immunohistochemistry (IF-IHC) was performed as per the protocol discussed here. To start with, slides were cleaned with neutral detergent, washed in running tap water for 30 min, and further dipped in 1% acidic ethanol followed by rinsing in deionised water. The slides were then coated with poly-L-lysine solution (1:10, diluted in deionised water), then kept overnight at room temperature. 3 μm sections were overlaid onto the coated slides and coded. At the beginning of the procedure, tissue sections were deparaffinized in the oven at 65°C, followed by immersing in 3 changes of xylene, 5 minutes each. The slides were then dipped in 100% and 95% ethanol for 2 changes of 5 minutes each, followed by immersing in 80%, 70% and 50% alcohol respectively, for 5 minutes each. Finally, slides were rinsed in running tap water for 15 minutes.
Pre-Treatment
Freshly prepared 0.1% sodium borohydride in phosphate
buffer saline (PBS, pH 7.4) was applied to sections for 2
changes, 2.5 minutes each without any in-between wash.
Then 0.5% crystal violet (10% stock in methanol) freshly
diluted in normal saline was laid on the sections for 9
minutes and drained. Lastly, 0.9% NaCl was overlaid on the
tissue, creating a bubble of liquid over the section for three
washes of 5 minutes each.
Epitope Retrieval
Sodium citrate buffer (0.01 M, pH=6) was preheated at
P-high (1350 watt) for 5 minutes, in a microwave oven.
The slides were immersed in this pre-warmed retrieval
solution and the sections boiled for 6 minutes at P-high.
After a pause of 1 minute to lower down the temperature of
retrieval solution, the sections were re-heated at P-40 (540
watt) for 9 minutes. The container was removed to room
temperature and the slides allowed to cool for 20 minutes.
On cooling, the slides were flushed in running tap water for
15 minutes. Excess water was drained-off from the slides
and the sections covered with PBS (pH=7.4), creating a
bubble of buffer over the tissue for 5 minutes.
Troubleshoot
Standardization of protocol was done by immersing the
slides directly in retrieval solution and boiling the sections
for 5 minutes at P-high, P-80 (1080 watt), P-60 (810 watt)
and P-40, which did not give satisfactory florescence signal
intensity.
Permeabilization
The sections were permeabilized by dipping in 0.2% Triton
X-100 in PBS (pH 7.4) for 45 minutes at room temperature.
Slides were rinsed and PBST (0.1% Tween in PBS) dropped
on the tissue, creating a layer of buffer over the section for
5 minutes.
Troubleshoot
1% Triton X-100 in PBS (pH 7.4) for 30 minutes at room
temperature
0.5% Triton X-100 in PBS (pH 7.4) for 45 minutes at room temperature
Both the above combinations did not yield desired results.
Blocking
70 μl blocking buffer (10% horse serum and 1% BSA in
PBS, pH=7.4) was pipetted onto the sections followed by
incubation in a humidified chamber at room temperature
for 1 h. Excess blocking buffer was drained off from the
slides before proceeding to the next step.
Troubleshoot
10% horse serum and 5% BSA in PBS, pH 7.4, at room
temperature for 1 h
9% horse serum and 3% BSA in PBS, pH 7.4, at room
temperature for 1 h
10% horse serum and 3% BSA in PBS, pH 7.4, at room
temperature for 1 h
10% horse serum and 2.5% BSA in PBS, pH 7.4, at room
temperature for 1 h
None of the above combinations yielded complete inhibition of non-specific binding.
Antigen Localization
70 μl of primary antibody hTERT (1:750 dilutions)
reconstituted in blocking buffer, was applied to the tissue
sections and incubated overnight at 4˚C in a humidified
chamber. After removal from the incubation chamber,
sections were covered with PBST for 5 minutes creating
a bubble and then rinsed with a gentle stream of PBST
(repeated thrice). Then sections were treated with 70 μl host
specific FITC labelled, secondary antibody (1:300 dilution)
re-constituted in PBS (pH 7.4). Sections were incubated for
60 minutes in the dark in a humidified chamber at room
temperature, followed by washing as mentioned for primary
antibody. Counterstaining of the sections was done using
DAPI (5 μg/ mL in PBS, pH 7.4) for 15 minutes in the dark
at RT, and then the slides were washed as described in the
permeabilization step. This procedure was repeated with
each of the other four antibodies on glioma tissue sections.
The specificity of each monoclonal antibody was checked
by western blot before application.
Final Treatment
After the counterstaining procedure, sections were treated
with a freshly prepared 0.1% solution of SBB in 70%
ethanol, for 5 minutes in the dark. Slides were then given
a final wash with PBST as per procedure followed earlier.
Throughout the procedure the tissue was not touched or
allowed to dry.
Mounting
Slides were mounted in the dark using antifade, placed on a
filter paper to drain excess mounting medium and allowed
to dry. The cover-slips were sealed with transparent nail
varnish and the slides were then kept for 1 hr at -20°C for
curing before visualizing.
The slides were stored in tight moisture-free boxes for 18- 24 months and could be reviewed thrice without fading of fluorescence signal. Each glioma sample was processed in duplicate sections for the complete procedure.
Microscopy
For epifluorescence microscopy, Axioskop 2 plus Imager
(Carl Zeiss, AG, Oberkochen, Germany) equipped with a
super high pressure mercury lamp (HBO 100) and VDS
high resolution (1280x1024 effective pixels) cooled chargecoupled
device-1300 (Hamamatsu Photonics, Hamamatsu,
Japan) was used. DAPI was detected using Zeiss-01 filter set
(excitation BP, 365/12 nm; beam splitter FT, 395; emission
LP, 397 nm) and FITC was detected using Zeiss-09 filter set
(excitation BP, 450/490 nm; beam splitter FT, 510; emission
LP, 515 nm). All images were observed with Plan-Neofluar
40 X 0.75 NA lens. With regard to the protein assessed,
areas with highest protein labeling were considered.
Approximately 1000 cells per section were randomly
selected and captured with 400x magnification followed
by digitalization and analysis with the Case Data Manager
Expo 4.5 software (Applied Spectral Imaging, Edingen
Neckarhausen, Germany). These images were exported
as TIFF files to Image-J software (version 1.45, National
Institute of Health, USA) for quantification of fluorescence
signals of interest.
Quantification of fluorescence signals: Image-J software generated data on fluorescence signal intensity was analyzed separately by two different observers. The results were compared and found to be reproducible. The procedure adopted for this was as follows: an outline was drawn around each positively expressing cell, for calculating the area under consideration, mean fluorescence and integrated density. This step was repeated for adjacent background by creating a grid. The corrected total cellular fluorescence (CTCF) was calculated as = Integrated density - (area of selected cell × mean fluorescence of background).The value of CTCF for treated cells was then equalized against the CTCF of untreated cells in the same field of view and results compiled for the trio treatment.
Statistical Analysis
Quantitative assessment of specifically labeled signal with
increased intensity after the triple reagent treatment was
compared with signals of paired untreated sections using
Wilcoxon matched-pairs signed rank test (two-tailed
Students t-test; non-parametric). Results are presented as
median values with inter quartile range (IQR=Q1-Q3).
All analysis was done using the Graph Pad Prism software
(version 7.03).
To validate staining integrity following our triple treatment protocol, we took a two-pronged approach: staining of the tissue specimen by conventional IF protocol (Figure 2A), and staining of section from the same block with selected reagents. All test reagent incubations were performed at RT. For all reagents, various concentrations as well as incubation periods were tested until a satisfactory result was obtained or it failed. A single application of 0.1% sodium borohydride resulted in slight dampening of autofluorescent background (Figure 2B). 0.5% crystal violet treatment (Figure 2C) resulted in partial quenching of background with maximization of both specific and nonspecific signals. Lone application of 0.1% SBB for 5 minutes (Figure 2D) eliminated background autofluorescence but also led to a drastic reduction of both specific and nonspecific signal intensities. Therefore, sodium borohydride, crystal violet and SBB, the most promising candidates, were selected for further study.
Combinational testing for treatment sequence was then performed to attain the best possible signals for protein of interest; and to achieve reproducible observations and imaging. The combination of sodium borohydride, crystal violet and SBB, in this specific order, resulted in complete dampening of autofluorescent background, masking of lipofuscin and non-specific signals; with brighter/ more intense fluorescent signal of the tagged protein (Figure 2E) as compared to these treatments alone or a combination (refer Figure 3 for CTCF values of treatments 2A to 2E).
Dealing with the other element, namely red blood cells, which exhibit green fluorescence that overlaps in the FITC channel (as seen in conventionally treated section, Figure 2F); our novel trio treatment resulted in total quenching of blood vessel autofluorescence as shown in Figure 2G. Thereafter, the order for this optimal staining combination was fixed as sodium borohydride followed by crystal violet treatment before antigen retrieval step and SBB treatment after staining with DAPI. This proved to be best suited for diminishment of autofluorescent background and nonspecific binding; paving way for successful visualization of the fluorescence tagged marker.
The increased intensity of desired signal achieved by our trio treatment has also enabled us to overcome the limitation of archiving IF labelled sections, facilitating storage for as long as 24 months with periodic review and without fading of the signal (Figure 2H, 2I; refer to Figure 3 for CTCF value). This is a huge increment on the previously reported storage period of 9 months (2). The method was also successfully assessed and validated using 3 other antibodies, with both nuclear and cytoplasmic expression (HMGA1, Synaptophysin, KIF- 14) (Figure 4A-C).
The current standardized IF-IHC protocol also has potential application on varied vascular tissue types as well as frozen brain sections, with results comparable to archival tissue (Figure 5). A negative control to check non-specific binding of secondary antibody was also employed for the fluorescence tagged molecule. No evidence of secondary antibody-induced background fluorescence (non-specific fluorescence signal) was observed for hTERT protein.
Subsequently, the above standardized method was validated on different tissue samples and controls. The expression of hTERT was negative in non-malignant brain tissue samples; while it was up-regulated in different tumors types.
To validate the results, a quantitative analysis of 10 paired glioma tissue sections was carried out. CTCF was calculated for positive cells and background in each of these sections. The Wilcoxon signed-rank paired t-test showed that signal intensity of protein expressing cells in terms of CTCF of treated sections (median 3261.80 (IQR 1780.44-6075.93)) was significantly higher than CTCF of untreated sections (median 1164.54 (IQR 574.925-2225.10), p=0.002). However, the signal intensity of the background in treated sections was significantly lower (median 235.174 (IQR 46.27-570.32)) than the background of untreated sections (median 2950.79 (IQR 742.71-5340.73), p=0.002), validating our methodology (Table I).
Our reagent selection was led by protocols frequently reported in the literature for quenching autofluorescence; hence sodium borohydride, crystal violet, UV-treatment, SBB, copper sulphate and ammonium chloride were selected to obtain a reduction in background. Santhosh Kumar and co-workers have recommended the use of UVlight[17]. Nybo has employed ammonium chloride to quench autofluorescence[18], while Spitzeret et al. have suggested the use of copper sulphate with ammonium acetate for achieving the desired results[19].
Sodium borohydride (1% in phosphate buffer) treatment has been used for both antigen retrieval and to reduce aldehyde induced autofluorescence of formalin fixed tissue[20]. Crystal violet treatment of FFPE tissue sections is cited to reduce the endogenous autofluorescence[21] while allowing IF staining with FITC conjugated antibodies[22]. Tissue treatment with 0.1% SBB in 70% ethanol has also been suggested as a good method to reduce/ eliminate tissue autofluorescence and background, while preserving the specific fluorescence signals[23,24]. In a study by Viegas et al. a combination of short-duration, high-intensity UV irradiation and SBB has been suggested as a better approach to reduce autofluorescence in highly vascular, high lipofuscin containing murine kidney tissues[25]. Another documentation of sequential treatments by Kajimura et al. advocates the use of 0.1% sodium borohydride followed by 0.3% SBB in 70% ethanol as an effective procedure for decreasing autofluorescence[26]. However, the current novel trio-treatment of sodium borohydride, crystal violet and SBB gave best reproducible results in all tissues types with both nuclear and cytoplasmic antigen localization, without compromising the signal intensity on extended storage.
Our study outcome thus clearly indicates that this indirect- IF based triple treatment methodology is able to provide successful quantifiable observations with a dampening of autofluorescence and non-specific background fluorescence, findings that can be extrapolated to other vascular human FFPE tissues and cryo sections for different protein targets.
CONFLICT of INTEREST
The authors declare that there are no competing interests.
ACKNOWLEDGEMENTS
The authors are thankful to M.P. Biotech Council, M.P.
(project no.249) for financial assistance and BMHRC
for infrastructural facilities. The present study is part
of approved project IEC/21/Res/11. The authors kindly
acknowledge Dr. Nitin Garg and Dr. Sandeep K Sorte,
Dept. of Neurosurgery for referral of glioma cases. The
authors are also thankful to Ms. Kavita Niraj for assistance
in literature survey and standardization of protocol, to
Dr. Hunni Gulwani and staff of Histopathology, Dept. of
Pathology, for providing tissue sections.
1) Schneider GEM, Straub CJ, Panzanelli P, Weinmann O, Sassoè-
Pognetto M, Fritschy JM. Immunoflorescence in brain sections:
Simultaneous detection of presynaptic and postsynaptic proteins
in identified neurons. Nat Protoc. 2006;1:1887-97.
2) Robertson D, Savage K, Reis-Filho JS, Isacke CM. Multiple
immunofluorescence labelling of formalin-fixed paraffinembedded
(FFPE) tissue. BMC Cell Biol. 2008;9:13.
3) Ramos-Vara JA, Miller MA. When tissue antigens and
antibodies get along: Revisiting the technical aspects of
immunohistochemistry-the red, brown, and blue technique. Vet
Pathol. 2014;51:42-87.
4) Rizzardi AE, Johnson AT, Vogel RI, Pambuccian SE, Henriksen J,
Skubitz AP, Metzger GJ, Schmechel SC. Quantitative comparison
of immunohistochemical staining measured by digital image
analysis versus pathologist visual scoring. Diagn Pathol.
2012;7:42.
5) Billinton N, Knight AW. Seeing the wood through the trees: A
review of techniques for distinguishing green fluorescent protein
from endogenous autofluorescence. Anal Biochem. 2001;291:175-97.
6) Casella GT, Bunge MB, Wood PM. Improved immunocytochemical
identification of neural, endothelial, and inflammatory
cell types in paraffin-embedded injured adult rat spinal cord. J
Neurosci Methods. 2004;139:1-11.
7) Croce AC, Bottiroli G. Autofluorescence spectroscopy and
imaging: A tool for biomedical research and diagnosis. Eur J
Histochem. 2014;58:2461.
8) Jung T, Bader N, Grune T. Lipofuscin: Formation, distribution,
and metabolic consequences. Ann N Y Acad Sci. 2007;1119:97-111.
9) P erse M, Injac R, Erman A. Oxidative status and lipofuscin
accumulation in urothelial cells of bladder in aging mice. PL oS
One. 2013;8:e59638.
10) Chen Jie, Laramore C, Shifman M. Triple-labeling whole-mount
in situ hybridization method for analysis of overlapping gene
expression in brain tissue with high level of autofluorescence. J
Cytol Histol. 2015;S3:011.
11) Diez-Fraile A, Van Hecke N, Guerin CJ, DHerde K. Optimizing
multiple immunostaining of neural tissue. In: Deghani H,
editor. Applications of immunocytochemistry. Rijeka: Tech
Publishing;2012. 29-48.
12) L u MH, Liao ZL, Zhao XY, Fan YH, Lin XL, Fang DC, Guo H,
Yang SM. hTERT-based therapy: A universal anticancer approach
(Review). Oncol Rep. 2012;28:1945-52.
13) Jun Li, Cao X, Fang Y, Liao ZE, Liu YY, Huang BD, Han YJ.
Overexpression of hTERT in potentially malignant colorectal
laterally spreading tumors. Mol Med Rep. 2013;7:1409-12.
14) Guan GG, Wang WB, Lei BX, Wang QL, Wu L, Fu ZM, Zhou FX,
Zhou YF. UBE2D3 is a positive prognostic factor and is negatively
correlated with hTERT expression in esophageal cancer. Oncol
Lett. 2015;9:1567-74.
15) Glass G, Papin JA, Mandell JW. SIMPL E: A sequential
immunoperoxidase labeling and erasing method. J Histochem
Cytochem. 2009;57:899-905.
16) Boenisch T. Handbook on immunohistochemical staining
methods. 3rd ed. Carpenteria, California, DAKO
Corporation;2001. 34-8.
17) Kumar SB, Sandhyamani S, Nazeer SS, Jayasree RS. Rapid
and simple method of photobleaching to reduce background
autofluorescence in lung tissue sections. Indian J Biochem
Biophys. 2015;52:107-10.
18) N ybo K. GFP imaging in fixed Cells. Biotechniques. 2012;52:359-60.
19) Spitzer N, Sammons GS, Price EM. Autofluorescent cells in rat
brain can be convincing impostors in green fluorescent reporter
studies. J Neurosci Methods. 2011;197:48-55.
20) Chen X, Cho DB, Yang PC. Double staining immunohistochemistry.
N Am J Med Sci. 2010;2:241-5.
21) Buchynska L, Kashuba E, Szekely L. Immunofluorescence staining
of paraffin sections: Creating DAB staining like virtual digital
images using CMYK color conversion. Exp Oncol. 2008;30:327-9.
22) Kong J, Ringer DP. Scanning microfluorometric analysis of
proliferating cell nuclear antigen in formalin-fixed sections of
hyperplastic and neoplastic rat liver. Cytometry. 1995;20:86-93.
23) O liveira VC, Carrara RCV, Simoes DLC, Saggioro FP, Carlotti
CG, Covas DT, Neder L. Sudan Black B treatment reduces
autofluorescence and improves resolution of in situ hybridization
specific fluorescent signals of brain sections. Histol Histopathol.
2010;25:1017-24.
24) Sun Y, Hong Y, Zheng D, Cao Q, Wang Y, Harris D, Wang Y.
Sudan Black B reduces autofluorescence in murine renal tissue.
Arch Pathol Lab Med. 2011;135:1335-42.